Structure

InChI Key USZYSDMBJDPRIF-SVEJIMAYSA-N
Smile CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC
InChI
InChI=1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C42H53NO15
Molecular Weight 811.88
AlogP 3.16
Hydrogen Bond Acceptor 16.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 9.0
Polar Surface Area 217.05
Molecular species BASE
Aromatic Rings 2.0
Heavy Atoms 58.0

Pharmacology

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials
Myelodysplastic Syndromes 1 D009190 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 57576-44-0
ChEBI 77980
ChEMBL CHEMBL502620
DrugBank DB11617
DrugCentral 80
EPA CompTox DTXSID1022554
FDA SRS 74KXF8I502
KEGG C18638
PubChem 451415
SureChEMBL SCHEMBL4532
ZINC ZINC000085537142